1 2 3 4 5 6 7 8 9 10 11 12 13 14
далее oteinuria in congestive heart failure. Am. J. Nephrol. 1983; 3: 272-275. 9 Михайлов А. А. Почки при сердечной недостаточности. В кн.: Тареев E. М. (ред.) Основы нефрологии. М.: Медицина; 1972. 555-560. 10. Kaila P. A., Raghavan C., Hassan R. et al. Nephrotic-range proteinuria associated with right atrial myxoma. Clin. Nephrol. 1992; 37: 294-296. 11. Bortolotto L. A., Silva Н. В., Galvao L. F. et al. Proteinuria in patients with congestive'heart failure. Role of arterial hypertension. Arq. Bras. Cardiot. 1993; 60: 243—245. 12. Schner R. W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis and pregnancy. N. Engl. J. Med. 1988; 319: 1065-1072. 13. Abraham W. Т., Schrier R. W. Renal function in congestive heart failure. In: Greenberg A., ed. Primer on kidney diseases. 2"'ed. San-Diego: Academic Press; 1998. 183—187. 14. Hall W. D. Abnormalities of kidney function as a cause and a consequence of cardiovascular disease. Am. J. Med. Sci.1999; 317- 176-182. 15. Matsusaka I., Hymes J., Ischikawa f. Angiotensin in progressive renal diseases: theory and practice. J. Am. Soc. Nephrol. 1996; 7: 2025-2043. 16. Wolf G. Angiotensin II: a pivotal factor in the progression of renal disease. Nephrol. Dial. Transplant. 1999; 14 (suppl. I): 42-44. 17. Matsushima Н., Yoshida Н., Machiguchi T. et al. Urinary albumin and TGF-1 levels as renal damage indices in patients with congestive heart failure. Clin. Exp. Nephrol. 2002; 6: 21-29. 18. Yoshida Н., Yashiro М., Liang P. et al. Mesangiolytic glomeru lopathy in severe congestive heart failure. Kidney Int. 1998; 53:880-891. 19. Goldfarb М., Abassi Z., Rosen S. Compensated heart failure predisposes to outer medullary tubular injury: studies in rats. Ibid. 2001; 60: 607—613. 20. Remutv G., Bertani T. Pathophysiology of progressive nephropathies. N. Engl. J. Med. 1998; 339: 1448-1456. 21. Ruggenenti P., Schiepatti A., Remuu.i G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601— 1608. 22. Locatelli F., Carbons I., Maschio G. et al. Long-term progression of chronic renal insufficiency in the AIPR1 Extension Study. Kidney Int. 1997; 52 (suppl. 63): 63—66. 23. Riiggenenti P., Perna A., Gherardi G. et al. Renoprotective properties of ACE-inhibitors in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 1999; 354: 359—364. 24. Parv'mg H.-ff., Lehnert Н., Brochner-Mortensen J. et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N. Engl. J. Med. 2001; 345: 870-878. 25. Pitt В., Pools- Wilson P. A., Segal R. et al. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomized trial — the Losartan Heart Failure Survival Study ELITE II. Lancet 2000; 355: 1582— 1587. 26. Cohn J., Tognoni G. for the Valsartan Heart Failure Trial In vestigators. A randomized trial of the angiotensin-receptor blocker valsartan in chro далее ...